Veracyte (VCYT) Tops Q4 EPS by 14c ; Offers Guidance

Veracyte (NASDAQ: VCYT) reported Q4 EPS of $0.53, $0.14 better than the analyst estimate of $0.39. Revenue for the quarter came in at $140.6 million versus the consensus estimate of $132.43 million.

GUIDANCE:

Veracyte sees FY2026 revenue of $570-582 million, versus the consensus of $570.3 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Boeing wins $2 billion satellite contract from DoW
• Enanta Pharma loses appeal in Pfizer Paxlovid patent case